Seres Therapeutics, Inc.

MCRBNASDAQ • USD
1.41 USD
↗ 0.01 (0.71%)AT CLOSE (03:59 PM EST)
1.48
↗ 0.07 (5.25%)
POST MARKET (AS OF 07:56 PM EST)
Post Market
AS OF 07:56 PM EST
1.48
↗ 0.07 (5.25%)
🔴Market: CLOSED

Seres Therapeutics, Inc. (MCRB) trades at $1.39 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.38
High?$1.70
Low?$1.38
Prev. Close?$1.40
Volume?186.6K
Avg. Volume?83.4K
VWAP?$1.51
Rel. Volume?2.24x
Bid / Ask
Bid?$1.35 × 200
Ask?$1.54 × 100
Spread?$0.19
Midpoint?$1.45
Valuation & Ratios
Market Cap?14.3M
Shares Out?10.2M
Float?7.1M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.67
EPS?-$4.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
14.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
18
Short Sent.?
64
Piotroski F-Score?1/9Weak
Altman Z-Score?-24.75Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?4.80%Low
Short Interest?342.2K
Days to Cover?4.3
Free Float7.1M
Avg Daily Volume79.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.65Adequate
Quick Ratio?1.65Adequate
Cash Ratio?0.84Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.67CHEAP▾
P/S?
Peers
100
S&P
18
6.72FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP▾
EV/Sales?
S&P
97
-1.53CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-219.8%WEAK▾
ROA?
S&P
3
-71.3%WEAK▾
Cash Flow & Enterprise
FCF?$-63970000
Enterprise Value?$-3254957
Fundamentals ratios updated end of day